{"id":662,"date":"2013-11-10T21:46:53","date_gmt":"2013-11-10T21:46:53","guid":{"rendered":"http:\/\/www.wi.rwth-aachen.de\/SmartMedCN\/?p=662"},"modified":"2013-11-10T21:46:53","modified_gmt":"2013-11-10T21:46:53","slug":"gsk-likely-to-avoid-company-wide-bribery-charge-in-china","status":"publish","type":"post","link":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/2013\/11\/10\/gsk-likely-to-avoid-company-wide-bribery-charge-in-china\/","title":{"rendered":"GSK Likely to Avoid Company-wide Bribery Charge in China"},"content":{"rendered":"<p><strong>GlaxoSmithKline, the British drug company at the heart of a bribery investigation in China, is likely to avoid a company-wide charge for allegedly funnelling up to \u00a3300m in kickbacks to doctors and government officials. Instead, police are likely to charge some of its Chinese executives, according to reports citing legal and industry sources.(Source: The Telegraph)<\/strong><\/p>\n<p>&nbsp;<\/p>\n<h3>\u845b\u5170\u7d20\u516c\u53f8\u88ab\u66dd\u5c06\u514d\u906d\u884c\u8d3f\u8d77\u8bc9 \u6216\u4ec5\u5bf9\u9ad8\u7ba1<\/h3>\n<p>\u6765\u6e90\uff1a\u8bc1\u5238\u65f6\u62a5\u7f51<br \/>\n\u6838\u5fc3\u63d0\u793a\uff1a\u65b0\u534e\u7f51\u63f4\u5f15\u5317\u4eac\u5546\u62a5\u62a5\u9053\u79f0\uff0c\u6628\u65e5\uff0c\u6709\u6cd5\u5f8b\u754c\u548c\u884c\u4e1a\u6d88\u606f\u4eba\u58eb\u79f0\uff0c\u4e2d\u56fd\u8b66\u65b9\u9488\u5bf9\u845b\u5170\u7d20\u53f2\u514b\u7684\u8c03\u67e5\uff0c\u6700\u7ec8\u53ef\u80fd\u4ec5\u662f\u8be5\u516c\u53f8\u4e00\u4e9b\u4e2d\u56fd\u9ad8\u7ba1\u9762\u4e34\u8bc9\u8bbc\uff0c\u516c\u53f8\u672c\u8eab\u6216\u514d\u4e8e\u8d77\u8bc9\u3002<\/p>\n<p>\u65b0\u534e\u7f51\u63f4\u5f15\u5317\u4eac\u5546\u62a5\u62a5\u9053\u79f0\uff0c\u6628\u65e5\uff0c\u6709\u6cd5\u5f8b\u754c\u548c\u884c\u4e1a\u6d88\u606f\u4eba\u58eb\u79f0\uff0c\u4e2d\u56fd\u8b66\u65b9\u9488\u5bf9\u845b\u5170\u7d20\u53f2\u514b\u7684\u8c03\u67e5\uff0c\u6700\u7ec8\u53ef\u80fd\u4ec5\u662f\u8be5\u516c\u53f8\u4e00\u4e9b\u4e2d\u56fd\u9ad8\u7ba1\u9762\u4e34\u8bc9\u8bbc\uff0c\u516c\u53f8\u672c\u8eab\u6216\u514d\u4e8e\u8d77\u8bc9\u3002<\/p>\n<p>\u636e \u62a5\u9053\uff0c\u4e00\u4f4d\u6d88\u606f\u4eba\u58eb\u8868\u793a\uff0c\u8b66\u65b9\u5bf9\u845b\u5170\u7d20\u53f2\u514b\u884c\u8d3f\u6848\u7684\u8c03\u67e5\u53ef\u80fd\u5728\u4eca\u5e7411\u6708\u5e95\u621612\u6708\u7ed3\u675f\u3002\u4f46\u6700\u7ec8\u5f88\u53ef\u80fd\u662f\u8be5\u516c\u53f8\u4e2d\u56fd\u533a\u591a\u540d\u9ad8\u7ba1\u88ab\u8d77\u8bc9\u3002\u4e8b\u5b9e\u4e0a\uff0c\u5982\u679c\u845b\u5170\u7d20 \u53f2\u514b\u516c\u53f8\u6ca1\u6709\u53d7\u5230\u6307\u63a7\uff0c\u5bf9\u5176\u5728\u534e\u4e1a\u52a1\u7684\u51b2\u51fb\u5c06\u5927\u5e45\u964d\u4f4e\u3002\u5bf9\u6b64\uff0c\u845b\u5170\u7d20\u53f2\u514b\u4e2d\u56fd\u516c\u53f8\u5728\u7ed9\u5317\u4eac\u5546\u62a5\u8bb0\u8005\u53d1\u6765\u7684\u56de\u5e94\u4e2d\u79f0\uff0c\u201c\u8c03\u67e5\u8fd8\u5728\u8fdb\u884c\u4e2d\uff0c\u6211\u4eec\u6b63\u5728\u5168\u529b\u914d\u5408\u653f \u5e9c\u90e8\u95e8\u3002\u8c03\u67e5\u662f\u4f9d\u7167\u4e2d\u56fd\u6cd5\u5f8b\u8fdb\u884c\u7684\uff0c\u845b\u5170\u7d20\u53f2\u514b\u5bf9\u6b64\u5145\u5206\u5c0a\u91cd\u3002\u5728\u76ee\u524d\u9636\u6bb5\uff0c\u6211\u4eec\u4e0d\u4fbf\u8fdb\u884c\u66f4\u591a\u8bc4\u8bba\u201d\u3002<\/p>\n<p>\u65e0\u72ec\u6709\u5076\uff0c\u540c\u65e5\u6d88\u606f\uff0c\u7f8e\u56fd\u53f8\u6cd5\u90e8\u53d1\u8868\u58f0\u660e\u8bf4\uff0c\u4e3a\u4e86\u7ed3\u5bf9\u8fdd\u6cd5\u9500\u552e\u836f\u54c1\u548c\u5411\u533b\u751f\u53ca\u836f\u5546\u63d0\u4f9b\u56de\u6263\u7684\u5211\u4e8b\u53ca\u6c11\u4e8b\u6307\u63a7\uff0c\u7f8e\u56fd\u5f3a\u751f\u516c\u53f8\u5c06\u652f\u4ed8\u8d85\u8fc722\u4ebf\u7f8e\u5143\u7f5a\u91d1\u3002\u8fd9\u662f\u7f8e\u56fd\u533b\u7597\u4fdd\u5065\u884c\u4e1a\u7b2c\u4e09\u5927\u7f5a\u6b3e\uff0c\u6b64\u6b21\u7f5a\u6b3e\u5305\u62ec4.85\u4ebf\u7f8e\u5143\u5211\u4e8b\u7f5a\u6b3e\u548c\u5411\u8054\u90a6\u53ca\u5dde\u653f\u5e9c\u652f\u4ed8\u768417.2\u4ebf\u7f8e\u5143\u6c11\u4e8b\u7f5a\u6b3e\u3002\u6709\u4e1a\u5185\u4eba\u58eb\u8ba4\u4e3a\uff0c\u540c\u6837\u662f\u6d89\u5acc\u533b\u836f\u5546\u4e1a\u8d3f\u8d42\uff0c\u5f3a\u751f\u516c\u53f8\u906d\u9047\u8bc9\u8bbc\uff0c\u90a3\u4e48\u845b\u5170\u7d20\u53f2\u514b\u516c\u53f8\u5728\u534e\u4e5f\u4e0d\u5e94\u5e78\u514d\u3002<\/p>\n<p>\u56fd\u9645\u6cd5\u4e13\u5bb6\u90dd\u4fca\u6ce2\u5206\u6790\uff0c\u56e0\u672a\u89c1\u5230\u4efb\u4f55\u8bc1\u636e\u6240\u4ee5\u5f88\u96be\u5224\u65ad\u6709\u5173\u7684\u884c\u8d3f\u5230\u5e95\u662f\u845b\u5170\u7d20\u53f2\u514b\u516c\u53f8\u6240\u505a\u51fa\u7684\u5355\u4f4d\u884c\u4e3a\uff0c\u8fd8\u662f\u884c\u8d3f\u4eba\u7684\u4e2a\u4eba\u884c\u4e3a\u3002\u4f46\u5982\u679c\u845b\u5170\u7d20\u53f2\u514b\u5411\u533b\u751f\u548c\u5b98\u5458\u884c\u8d3f\u5c5e\u5b9e\uff0c\u90a3\u672c\u6848\u4e2d\u5355\u4f4d\u884c\u8d3f\u7684\u53ef\u80fd\u6027\u8f83\u5927\u3002<\/p>\n<p>\u201c\u5982 \u679c\u6ca1\u6709\u845b\u5170\u7d20\u53f2\u514b\u4e2d\u56fd\u516c\u53f8\u5168\u4f53\u8d1f\u8d23\u4eba\u540c\u610f\uff0c\u5e76\u7ecf\u8fc7\u516c\u53f8\u7684\u5185\u90e8\u7a0b\u5e8f\uff0c\u6050\u6015\u4e2a\u4eba\u5f88\u96be\u52a8\u7528\u5de8\u989d\u8d44\u91d1\uff0c\u800c\u4e14\u884c\u8d3f\u7684\u7ed3\u679c\u5f88\u53ef\u80fd\u662f\u533b\u9662\u91c7\u8d2d\u6216\u66f4\u591a\u4f7f\u7528\u8be5\u516c\u53f8\u7684\u4ea7\u54c1\uff0c\u6240 \u4ee5\u8be5\u516c\u53f8\u4f1a\u4ece\u4e2d\u53d7\u76ca\u3002\u800c\u8fd9\u6b63\u597d\u7b26\u5408\u5355\u4f4d\u884c\u8d3f\u7684\u7279\u70b9\u3002\u201d \u90dd\u4fca\u6ce2\u8bf4\u3002\u4ed6\u8fd8\u5f3a\u8c03\uff0c\u5982\u679c\u845b\u5170\u7d20\u53f2\u514b\u88ab\u8ba4\u4e3a\u662f\u5355\u4f4d\u72af\u7f6a\uff0c\u5176\u6bcd\u516c\u53f8\u5728\u7f8e\u56fd\u4e5f\u4f1a\u88ab\u653f\u5e9c\u4f9d\u636e\u76f8\u5173\u53cd\u6d77\u5916\u8150\u8d25\u6cd5\u5904\u4ee5\u91cd\u7f5a\uff0c\u5176\u4e2d\u4e0d\u4ec5\u53ef\u80fd\u4f1a\u906d\u9047\u5de8\u989d\u7f5a\u6b3e\uff0c\u6709\u5173\u7684\u4eba\u5458 \u8fd8\u53ef\u80fd\u8981\u627f\u62c5\u5211\u4e8b\u8d23\u4efb\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>GlaxoSmithKline, the British drug company at the heart of a bribery investigation in China, is likely to avoid a company-wide charge for allegedly funnelling up to \u00a3300m in kickbacks to [&hellip;]<\/p>\n","protected":false},"author":951,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"c2c_always_allow_admin_comments":false,"footnotes":""},"categories":[5],"tags":[9],"class_list":["post-662","post","type-post","status-publish","format-standard","hentry","category-pharmaceutical-company-news","tag-corruption"],"_links":{"self":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts\/662","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/users\/951"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/comments?post=662"}],"version-history":[{"count":0,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts\/662\/revisions"}],"wp:attachment":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/media?parent=662"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/categories?post=662"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/tags?post=662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}